openPR Logo
Press release

Lawsuit filed for Investors in NASDAQ: OMCL shares against Omnicell, Inc.

07-22-2019 08:36 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Omnicell, Inc. (NASDAQ: OMCL) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Omnicell, Inc. (NASDAQ: OMCL) shares over alleged securities laws violations.

The Shareholders Foundation announces that an investor, who purchased shares of Omnicell, Inc. (NASDAQ: OMCL), filed a lawsuit over alleged violations of Federal Securities Laws by Omnicell, Inc.

Investors who purchased shares of Omnicell, Inc. (NASDAQ: OMCL) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Mountain View, CA based Omnicell, Inc. provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. On July 10, 2019, a report was published alleging Omnicell, Inc obfuscated its financials over the past two years "by using a variety of accounting gimmicks." After analyzing Omnicell's accounts receivable (AR), inventory, and capitalized expense diagnostics, the report concluded that Omnicell, Inc has prematurely recognized over $38 million in sales revenue, failed to write-off over $23 million in obsolete inventory, and has misclassified and accelerated the capitalization of over $38 million in expenses. Shares of Omnicell, Inc. (NASDAQ: OMCL) declined to $67.30 per share on July 12, 2019.

The plaintiff claims that between October 25, 2018 and July 11, 2019, the Defendants failed to disclose to investors that the Company recognized revenue for certain transactions before fulfilling its performance obligations, that the Company engaged in improper accounting practices to meet revenue targets, that the Company experienced weaker demand for new product lines than it had previously projected, that, as a result, the Company would be required to write-off certain inventory, that the Company misclassified certain expenses as capitalized expenditures, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations

Those who purchased shares of Omnicell, Inc. (NASDAQ: OMCL) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in NASDAQ: OMCL shares against Omnicell, Inc. here

News-ID: 1808732 • Views: 324

More Releases from Shareholders Foundation

Investigation announced for NYSE: COF Investors over possible Wrongdoing at Capi …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Capital One Financial Corporation. Investors who are current long term investors in Capital One Financial Corporation (NYSE: COF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: COF stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Acadia Healthcare Company Inc …
An investigation was announced for investors in shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) concerning potential breaches of fiduciary duties by certain directors at Acadia Healthcare Company Inc. Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) and currently hold any of those NASDAQ: ACHC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
Investigation for Investors in shares of PlayAGS, Inc. (NYSE: AGS) announced
An investigation was announced concerning potential securities laws violations by PlayAGS, Inc. in connection with certain financial statements. Investors who purchased shares of PlayAGS, Inc. (NYSE: AGS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of PlayAGS, Inc. (NYSE: AGS) concerning whether a series of statements
Lawsuit filed for Investors in shares of Spirit AeroSystems Holdings, Inc. (NYSE …
An investor, who purchased shares of Spirit AeroSystems Holdings, Inc. (NYSE: SPR), filed a lawsuit over alleged violations of Federal Securities Laws by Spirit AeroSystems Holdings, Inc. Investors who purchased shares of Spirit AeroSystems Holdings, Inc. (NYSE: SPR) have certain options and for certain investors are short and strict deadlines running. Deadline: April 10, 2020. NYSE: SPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Omnicell

High Volume Dispensing Systems Market - Insights On Future Scope 2028 | McKesson …
Global High Volume Dispensing Systems Market: Overview The global high volume dispensing systems market is anticipated to witness the rise of growing trends such as the increasing adoption of pharmacy automation software. The global high volume dispensing systems market could gain attention due to the rising incidence of medication errors and technological developments. In the U.S., nearly 1.3 million people have suffered injuries and at least one person loses life because
High Volume Dispensing Systems Market Drivers and Restraints 2028 : Innovation A …
Global High Volume Dispensing Systems Market: Overview The global high volume dispensing systems market is anticipated to witness the rise of growing trends such as the increasing adoption of pharmacy automation software. The global high volume dispensing systems market could gain attention due to the rising incidence of medication errors and technological developments. In the U.S., nearly 1.3 million people have suffered injuries and at least one person loses life because
Pharmacy Automation Market to Set Phenomenal Growth| Omnicell, YUYAMA, Swisslog, …
HTF MI presents an in-depth overview of the Global Pharmacy Automation Market Study, detailing the latest product / industry coverage and market forecasts and status by 2023. Market research is categorized as a key area to accelerate marketization. The current market is evolving its presence and some of the major players in the entire study are BD, Baxter International, TOSHO , Takazono, Omnicell, YUYAMA, Swisslog, Willach Group, Innovation, Parata, TCGRx,
Global Pharmacy Automation Systems Market 2019 - BD, Baxter International, TOSHO …
The new global "Pharmacy Automation Systems Market" report delivers a comprehensive and systematic framework of the Pharmacy Automation Systems market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Pharmacy Automation Systems market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on
Pharmacy Inventory Management Software Solutions and Cabinets Market - Developin …
Global Pharmacy Inventory Management Software Solutions and Cabinets Market: Overview Developments in the market for pharmacy inventory management software solutions and cabinets rides on the back of the rising adoption of automation solutions across the stages of healthcare delivery, including in pharmacy. World over, pharmacy managers are hard-pressed to reduce overhead cost and bring efficiency in managing inventory, boost inventory turns, and gain real-time visibility into the medication inventory. The drive
Global Pharmacy Automation Systems Market 2018 - Swisslog, Omnicell, YUYAMA, TOS …
Apex Market Research, recently published a detailed market research study focused on the "Pharmacy Automation Systems Market" across the global, regional and country level. The report provides 360° analysis of "Pharmacy Automation Systems Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Pharmacy Automation Systems industry, and estimates the future trend of